Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.56 |
| ▸ | PDE4A | P27815 | 8/20 | 0.48 |
| ▸ | PDE4B | Q07343 | 8/20 | 0.48 |
| ▸ | PDE4C | Q08493 | 8/20 | 0.48 |
| ▸ | PDE4D | Q08499 | 8/20 | 0.48 |
| ▸ | NEU3 | Q9UQ49 | 1/20 | 0.47 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.45 |
| ▸ | MRGPRX1 | Q96LB2 | 1/20 | 0.42 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 2/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29723405 | 1.00 | CYP19A1 (0.56) | CYP19A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL14481111 | 0.90 | PDE4A (0.49) | CYP19A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL2762046 | 0.89 | CYP19A1 (0.55) | CYP19A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL18830717 | 0.86 | CYP19A1 (0.50) | CYP19A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL18830796 | 0.86 | CYP19A1 (0.50) | CYP19A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL14798483 | 0.81 | CYP19A1 (0.39) | CYP19A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL5364834 | 0.81 | SMN1; SMN2 (0.58) | NEU3MEN1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL14799306 | 0.81 | TSHR (0.47) | PDE4APDE4BPDE4CPDE4DNR1H4 | |
| SCHEMBL14799138 | 0.81 | CYP19A1 (0.59) | CYP19A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL14799247 | 0.81 | CYP19A1 (0.59) | CYP19A1PDE4APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013087749-A1 | POTENTIATION INDUCED BY PDE4 INHIBITORS IN THE TREATMENT OF LEUKEMIA | CHIESI FARMACEUTICI S.P.A. (IT) | 2013-06-20 | — | — | WO | claimed |
| US-20240166605-A1 | PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR | CHIESI FARMACEUTICI S.P.A. (IT) | 2024-05-23 | — | — | US | disclosed |
| EP-3829641-B1 | NOVEL CARRIER PARTICLES FOR DRY POWDER FORMULATIONS FOR INHALATION | CHIESI FARM SPA (IT) | 2024-05-22 | — | — | EP | disclosed |
| US-11981639-B2 | Process for the preparation of a PDE4 inhibitor | CHIESI FARMACEUTICI S.P.A. (IT) | 2024-05-14 | — | — | US | disclosed |
| CN-112469443-B | Novel carrier particles for dry powder formulations for inhalation | 奇斯药制品公司 | 2024-04-16 | — | — | CN | disclosed |
| EP-3587400-B1 | PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR | CHIESI FARM SPA (IT) | 2024-03-20 | — | — | EP | disclosed |
| US-11813360-B2 | Carrier particles for dry powder formulations for inhalation | CHIESI FARMACEUTICI S.P.A. (IT) | 2023-11-14 | — | — | US | disclosed |
| EP-4059921-A1 | PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR | Chiesi Farmaceutici S.p.A. (IT) | 2022-09-21 | — | — | EP | disclosed |
| US-20220218678-A1 | USE OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES FOR TREATING CYSTIC FIBROSIS | CHIESI FARMACEUTICI S.P.A. (IT) | 2022-07-14 | — | — | US | disclosed |
| CN-114621139-A | Process for the preparation of PDE4 inhibitors | 奇斯药制品公司 | 2022-06-14 | — | — | CN | disclosed |
| US-9056176-B2 | 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors | CHIESI FARMACEUTICI S.P.A. (IT) | 2015-06-16 | — | — | US | disclosed |
| WO-2015059050-A1 | PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR | CHIESI FARMACEUTICI S.P.A. (IT) | 2015-04-30 | — | — | WO | disclosed |
| US-20150111931-A1 | PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR | CHIESI FARMACEUTICI S.P.A. (IT) | 2015-04-23 | — | — | US | disclosed |
| US-20140378423-A1 | 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2014-12-25 | — | — | US | disclosed |
| US-8648204-B2 | 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors | CHIESI FARMACEUTICI S.P.A. (IT) | 2014-02-11 | — | — | US | disclosed |
| WO-2013087749-A1 | POTENTIATION INDUCED BY PDE4 INHIBITORS IN THE TREATMENT OF LEUKEMIA | CHIESI FARMACEUTICI S.P.A. (IT) | 2013-06-20 | — | — | WO | disclosed |
| US-20130156865-A1 | POTENTIATION INDUCED BY PDE4 INHIBITORS IN THE TREATMENT OF LEUKEMIA | CHIESI FARMACEUTICI S.P.A. (IT) | 2013-06-20 | — | — | US | disclosed |
| EP-2600829-A2 | PHARMACEUTICAL FORMULATION COMPRISING A PHOSPHODIESTERASE INHIBITOR | Chiesi Farmaceutici S.p.A. (IT) | 2013-06-12 | — | — | EP | disclosed |
| US-20130012487-A1 | 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2013-01-10 | — | — | US | disclosed |
| WO-2012016845-A2 | PHARMACEUTICAL FORMULATION COMPRISING A PHOSPHODIESTERASE INHIBITOR | CHIESI FARMACEUTICI S.P.A. (IT) | 2012-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166605-A1 | PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR | PDE4A, PDE12, PDE4B | CYP19A1 939/4885PDE4A 1/4885PDE4B 3/4885 |
| US-20130012487-A1 | 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | PDE4A, PDE4B, PDE3A | CYP19A1 1081/4885PDE4A 1/4885PDE4B 2/4885 |
| US-20220218678-A1 | USE OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES FOR TREATING CYSTIC FIBROSIS | CFTR, CLIC1, CLCN2 | CYP19A1 4668/4885PDE4A 271/4885PDE4B 397/4885 |
| US-20140378423-A1 | 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | PDE4A, PDE4B, PDE3A | CYP19A1 1081/4885PDE4A 1/4885PDE4B 2/4885 |
| US-11981639-B2 | Process for the preparation of a PDE4 inhibitor | PDE4A, PDE12, PDE4B | CYP19A1 939/4885PDE4A 1/4885PDE4B 3/4885 |
| US-20130156865-A1 | POTENTIATION INDUCED BY PDE4 INHIBITORS IN THE TREATMENT OF LEUKEMIA | PDE4A, PDE4B, PDE4D | CYP19A1 2801/4885PDE4A 1/4885PDE4B 2/4885 |
| US-20150111931-A1 | PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR | PDE4A, PDE12, PDE4B | CYP19A1 939/4885PDE4A 1/4885PDE4B 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.